Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile', Immunotherapy, vol.2, issue.4, p.2941805, 2010. ,
Antigen-specific deletion of cloned T cells using peptidetoxin conjugate complexed with purified class II major histocompatibility complex antigen. The Journal of biological chemistry, vol.269, pp.94-103, 1994. ,
Targeted deletion of Tcell clones using alpha-emitting suicide MHC tetramers, Blood, vol.104, issue.8, pp.2397-402, 2004. ,
Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin, Blood, vol.109, issue.8, pp.3300-3307, 2007. ,
, , p.1852243
T-cell reconstitution without T-cell immunopathology in two models of T-cell-mediated tissue destruction, Immunology, vol.128, issue.2, p.2767306, 2009. ,
Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice, Journal of immunology, vol.184, issue.8, p.2868268, 2010. ,
Deletion of naive T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance, Transpl Immunol, vol.29, issue.1-4, p.3867971, 2013. ,
Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model, Epub 2005/11/05, vol.107, pp.2045-51, 2006. ,
, , p.1895712
Phenotypic analysis of antigen-specific T lymphocytes, Science, vol.274, issue.5284, pp.94-100, 1996. ,
MHC-peptide tetramers for the analysis of antigen-specific T cells. Expert review of vaccines, vol.9, pp.765-74, 2010. ,
One-pot, mix-andread peptide-MHC tetramers, PLoS One, vol.3, issue.2, p.2244712, 2008. ,
Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent, Journal of immunology, vol.163, issue.8, pp.4342-4350, 1999. ,
Increasing inflationary T-cell responses following transient depletion of MCMV-specific memory T cells, Eur J Immunol, vol.45, issue.1, p.4477908, 2015. ,
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome, J Virol, vol.68, issue.7, p.236393, 1994. ,
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection, J Virol, vol.68, issue.9, pp.6103-6113, 1994. ,
Efficacious early antiviral activity of HIV Gag-and Pol-specific HLA-B 2705-restricted CD8+ T cells, Journal of virology, vol.84, issue.20, p.2950555, 2010. ,
Vpr is preferentially targeted by CTL during HIV-1 infection, Journal of immunology, vol.167, issue.5, pp.2743-52, 2001. ,
Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcome, J Virol, vol.88, issue.21, p.4248916, 2014. ,
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection, AIDS, vol.17, issue.13, pp.1871-1880, 2003. ,
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy, J Infect Dis, vol.187, issue.10, pp.1534-1577, 2003. ,
Common and well-documented HLA alleles: report of the Ad-Hoc committee of the american society for histocompatiblity and immunogenetics, Human immunology, vol.68, issue.5, pp.392-417, 2007. ,
MHC-peptide tetramers to visualize antigen-specific T cells, Curr Protoc Immunol, vol.17, issue.3, 2003. ,
Purification of cytomegalovirus-specific CD8 T cells from peripheral blood using HLA-peptide tetramers, British journal of haematology, vol.115, issue.2, pp.428-462, 2001. ,
Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses, Nature protocols, vol.5, issue.6, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01420584
Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes, Journal of virology, vol.83, issue.7, pp.3138-3187, 2009. ,
Evaluation of antigen-specific responses using in vitro enriched T cells, J Immunol Methods, vol.274, issue.1-2, pp.139-186, 2003. ,
Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens, Journal of immunology, vol.139, issue.4, pp.1369-74, 1987. ,
Identification of dominant optimal HLA-B60-and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay, Journal of virology, vol.74, issue.18, p.116366, 2000. ,
Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load, Journal of virology, vol.77, issue.3, p.140965, 2003. ,
Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection, PLoS Pathog, vol.8, issue.3, 2012. ,
Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA, J Exp Med, vol.201, issue.6, pp.891-902, 2005. ,
Transient loss of MHC class I tetramer binding after CD8+ T cell activation reflects altered T cell effector function, Journal of immunology, vol.175, issue.3, pp.1507-1522, 2005. ,
Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1, Journal of virology, vol.86, issue.24, p.3503140, 2012. ,
Persistent survival of prevalent clonotypes within an immunodominant HIV gag-specific CD8+ T cell response, Journal of immunology, vol.186, issue.1, pp.359-71, 2011. ,
A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells, Immunity, vol.38, issue.3, pp.425-461, 2013. ,